The Business of Biofabrication

The Terasaki Institute for Biomedical Innovation has received an award of up to $19.8 million from ARPA-H to lead a multi-institution program developing transplantable, immune-compatible liver tissue. The project, called PROMETHEUS, is part of ARPA-H’s PRINT program and is led by Dr. Xiling Shen, Acting Director and Principal Investigator at the Terasaki Institute. The program…